Andrew Schiermeier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board

/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene.

United statesUnited kingdomSan franciscoWendy chungOrrin devinskySteve ruchefskyAndrew schiermeierNadav ahituvKevin benderGord fishellUniversity of californiaBroad instituteDepartment of neurologyHarvard medical schoolEpilepsy centerTherapeutic technology

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesNew orleansUnited kingdomAndrew schiermeierMartin wermkeGerhard ehningerAmerican society of hematologyAvencell therapeutics incBlackstone life sciencesCell therapeuticsCell candidateUniversal targetingAmerican societyAnnual meetingEarly clinical trial unitUniversity hospital carl gustav carus